Skip to main content

NVS · Novartis AG · Analyst Estimates

Track NVS — free
$140.77 -4.94 (-3.39%)
Market Cap
$276.48B
Shares
1.90B
Volume · Sep 30 3.06M Avg daily vol (3M) 1.93M

Analyst Estimates

Compare analyst forecasts for Novartis AG across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 07:25 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
8.62418
8.84802
9.04
—
8.82367
8.69234
8.80302
8.8372
— — — —
EPS
analysts
Publication date not stated
— — —
8
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
56112000000
57651275830
59883000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
9.3
9.83792
10.75
—
9.87256
9.76327
9.81014
9.93306
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
59262000000
61409412140
65817000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.20005
2.23002
2.26
—
2.23002
2.17123
2.23002
2.15682
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
2
Revenue
USD
Publication date not stated
14325310920
14661405250
15069000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.01413
2.10206
2.19
—
2.10281
2.30661
2.10281
2.30699
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
14391242130
14987253710
15270000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1114448 CUSIP 66987V109 13F (30d) 36 filings 20 filers Visit website Investor relations